Approval · Notice of Compliance 29632 · 2022
PREHEVBRIO: Notice of Compliance 29632
Issued December 6, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 29632
- Date
- December 6, 2022
- Company
- Vbi Vaccines Inc.Ottawa, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PREHEVBRIO | 02533286 | Approved |
Medicinal ingredients
- HEPATITIS B SURFACE ANTIGEN (RECOMBINANT) 10 MCG per ML